Td Waterhouse Canada Inc. Bristol Myers Squibb CO Transaction History
Td Waterhouse Canada Inc.
- $15.3 Trillion
- Q3 2025
A detailed history of Td Waterhouse Canada Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 15,089 shares of BMY stock, worth $706,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,089
Previous 229,861
93.44%
Holding current value
$706,316
Previous $10.9 Billion
93.45%
% of portfolio
0.0%
Previous 0.08%
Shares
17 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...